These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2907957)

  • 21. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
    Okuyama S; Shimamura H; Hashimoto S; Aihara H
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):246-54. PubMed ID: 3827410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electromyographical differentiation of the components of perioral movements induced by SKF 38393 and physostigmine in the rat.
    Collins P; Broekkamp CL; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1993; 112(4):428-36. PubMed ID: 7871053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two inbred rat sublines that differ in spontaneous yawning behavior also differ in their responses to cholinergic and dopaminergic drugs.
    Urbá-Holmgren R; Santos A; Holmgren B; Eguíbar JR
    Behav Brain Res; 1993 Sep; 56(2):155-9. PubMed ID: 7902098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of dopaminergic agents on visceral pain measured by the mouse writhing test.
    Frussa-Filho R; Rocha JB; Conceição IM; Mello CF; Pereira ME
    Arch Int Pharmacodyn Ther; 1996; 331(1):74-93. PubMed ID: 8896712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SKF 38393 potentiates yawning induced by LY 171555: further evidence against the autoreceptor hypothesis of yawning.
    Spina L; Longoni R; Mulas A; Di Chiara G
    Psychopharmacology (Berl); 1989; 98(4):567-8. PubMed ID: 2570436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effect of morphine on yawning induced by cholinoceptor and dopamine D2 receptor activation in rats.
    Zarrindast MR; Jamshidzadeh A
    Br J Pharmacol; 1992 Mar; 105(3):675-8. PubMed ID: 1385751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats.
    Jones CK; Eberle EL; Shaw DB; McKinzie DL; Shannon HE
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1055-63. PubMed ID: 15574685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible involvement of differing classes of dopamine D-2 receptors in yawning and stereotypy in rats.
    Yamada K; Nagashima M; Kimura H; Matsumoto S; Furukawa T
    Psychopharmacology (Berl); 1990; 100(2):141-4. PubMed ID: 1968276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of dopamine agonists in mature and immature rats.
    McDevitt JT; Setler PE
    Eur J Pharmacol; 1981 Jun; 72(1):69-75. PubMed ID: 6973482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre- and post-synaptic dopaminergic receptors involved in apomorphine-induced yawning.
    Urba-Holmgren R; Holmgren B; Anias J
    Acta Neurobiol Exp (Wars); 1982; 42(2):115-25. PubMed ID: 6891988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the participation of the dopaminergic system in the central effects of chelidonine.
    Kleinrok Z; Szponar J; Matuszek B; Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1990; 42(5):417-24. PubMed ID: 2098751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the effects of bifemelane hydrochloride and indeloxazine hydrochloride on scopolamine hydrobromide-induced impairment in radial maze performance.
    Ogawa N; Haba K; Sora YH; Higashida A; Sato H; Ogawa S
    Clin Ther; 1988; 10(6):704-11. PubMed ID: 3219685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The yawning behavior of rats following application of dopaminergic agonists--dose and time effect relationship].
    Stelzig S; Hoffmann W
    Pharmazie; 1988 Feb; 43(2):140-1. PubMed ID: 3393587
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of RG-tannin on yawning behaviour induced by apomorphine or physostigmine in rats.
    Starec M; Waitzová D; Elis J
    Act Nerv Super (Praha); 1989 Apr; 31(1):71-2. PubMed ID: 2571230
    [No Abstract]   [Full Text] [Related]  

  • 36. Involvement of central beta-adrenoceptors in the regulation of yawning responses.
    Yamada K; Matsumoto S; Nagashima M; Kumagai M; Kimura H; Furukawa T
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):26-30. PubMed ID: 2571945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of antidepressant drugs and different receptor antagonists on the grooming induced by the dopamine D-1 agonist SKF 38393.
    Skuza G; Rogóz Z; Zak J
    Pol J Pharmacol Pharm; 1989; 41(5):421-9. PubMed ID: 2577061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atropine increases pilocarpine-induced yawning behavior in paradoxical sleep deprived rats.
    Lobo LL; de Medeiros R; Hipólide DC; Tufik S
    Pharmacol Biochem Behav; 1995 Nov; 52(3):485-8. PubMed ID: 8545463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of lead exposure on licking and yawning behaviour in rats.
    Ghazi-Khansari M; Rezvani N; Bani-Assadi S; Zarrindast MR
    Pharmacol Toxicol; 1998 Sep; 83(3):120-4. PubMed ID: 9783330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of cholinergic and dopaminergic influences on yawning behavior.
    Holmgren B; Urbá-Holmgren R
    Acta Neurobiol Exp (Wars); 1980; 40(3):633-42. PubMed ID: 6969021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.